Stuart brings more than 20 years of drug discovery experience to his role, having progressed through a range of positions at Sygnature Discovery before being promoted in 2024. He has worked across diverse scientific approaches to deliver high-quality preclinical candidates and is highly skilled in guiding biotechnology partners through the discovery process. Stuart has led multiple medicinal chemistry programs, contributing five compounds to ongoing clinical trials, and more recently oversaw the discovery of two first-in-class preclinical anti-infective agents. He is an inventor on more than thirty patents and has authored eleven publications.<\/p>\n\n\n\n
Stuart holds a first-class degree in Medicinal Chemistry and a PhD in Supra-molecular Chemistry, and previously served as a Non-Executive Director of Peak Proteins.<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":9199,"template":"","team_group":[642,667],"class_list":["post-1408","people","type-people","status-publish","has-post-thumbnail","hentry","team_group-executive-leadership-team","team_group-research-management-team"],"acf":[],"yoast_head":"\n